Arginase-dependent suppression by CpG-ODN plus IFA-induced splenic myeloid CD11b(+)Gr1(+) cells
- PMID: 22083526
- DOI: 10.1038/icb.2011.98
Arginase-dependent suppression by CpG-ODN plus IFA-induced splenic myeloid CD11b(+)Gr1(+) cells
Abstract
The ability of synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (CpG-ODN) to induce both stimulatory and counter-regulatory responses offers novel opportunities for using these molecules as immunomodulatory agents in different therapeutic strategies. Here, we investigated the potential of CpG-ODN to activate the arginase (ARG) enzyme in vivo and focused on the consequences of this activation in T-cell proliferation. Challenging mice subcutaneously with CpG-ODN emulsified in incomplete Freund's adjuvant (IFA) induced ARG and reduced T-cell proliferation associated with CD3ζ chain downregulation. Interestingly, impaired T-cell expansion correlated with elevated levels of CD11b(+)Gr1(+) myeloid cells localized near T-cell areas in the spleen. In addition, purified CD11b(+) cells obtained from the spleen of CpG-ODN+IFA-treated mice exhibited increased ARG activity and ARG I expression along with an augmented [(3)H]-L-arginine uptake. CD11b(+) myeloid cells significantly suppressed T-cell proliferation and CD3ζ chain expression induced by a polyclonal stimulus. Furthermore, these effects could be recovered by the addition of excess L-arginine or by treatment of CD11b(+) cells with a specific ARG inhibitor. This study provides a novel evidence that CpG-ODN+IFA are able to induce splenic CD11b(+) cells with ARG activity, with this population being responsible for the impaired T-cell proliferation observed after the treatment with CpG-ODN+IFA. These results underscore a key role of CpG-ODN on ARG activity in vivo and add support to the growing body of evidence in favor of a counter-regulatory role for CpG-ODN in an immune response.
Similar articles
-
Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment.Oncotarget. 2015 May 30;6(15):13448-61. doi: 10.18632/oncotarget.3626. Oncotarget. 2015. PMID: 25922914 Free PMC article.
-
CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy.Biol Blood Marrow Transplant. 2008 Sep;14(9):973-984. doi: 10.1016/j.bbmt.2008.06.018. Biol Blood Marrow Transplant. 2008. PMID: 18721760
-
CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress.J Immunol. 2006 Feb 15;176(4):2085-94. doi: 10.4049/jimmunol.176.4.2085. J Immunol. 2006. PMID: 16455964
-
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.Immunol Rev. 2008 Apr;222:180-91. doi: 10.1111/j.1600-065X.2008.00608.x. Immunol Rev. 2008. PMID: 18364002 Free PMC article. Review.
-
L-arginine metabolism in myeloid cells controls T-lymphocyte functions.Trends Immunol. 2003 Jun;24(6):302-6. doi: 10.1016/s1471-4906(03)00132-7. Trends Immunol. 2003. PMID: 12810105 Review.
Cited by
-
Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant N-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein.Int J Mol Sci. 2021 Jun 26;22(13):6892. doi: 10.3390/ijms22136892. Int J Mol Sci. 2021. PMID: 34206987 Free PMC article.
-
Oligodeoxynucleotides containing unmethylated cytosine-guanine motifs are effective immunostimulants against pneumococcal meningitis in the immunocompetent and neutropenic host.J Neuroinflammation. 2021 Feb 2;18(1):39. doi: 10.1186/s12974-021-02077-3. J Neuroinflammation. 2021. PMID: 33531028 Free PMC article.
-
Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment.Oncotarget. 2015 May 30;6(15):13448-61. doi: 10.18632/oncotarget.3626. Oncotarget. 2015. PMID: 25922914 Free PMC article.
-
The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.Theranostics. 2018 Feb 12;8(6):1723-1739. doi: 10.7150/thno.22056. eCollection 2018. Theranostics. 2018. PMID: 29556352 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials